ReportsnReports.com

Global Hypertension Drugs Market 2014-2018 New Report

 
Repost This

Dallas, TX -- (SBWIRE) -- 04/10/2014 -- ReportsnReports.com adds Global Hypertension Drugs Market 2014-2018 new report in its store.Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle habits such as diet, exercising, and smoking are the major causes of hypertension. Hypertension can damage organs and lead to several illnesses such as renal failure, aneurysm, heart failure, stroke, and heart attack. There are two types of hypertension: primary or essential and secondary.

Analysts forecast the Global Hypertension Drugs market will grow at a CAGR of 1.2 percent over the period 2013-2018.

Covered in this Report
The Global Hypertension Drugs market can be categorized into eight segments: Diuretics, ACE Inhibitors, ARBs, CCB, Beta Blockers, Alpha Blockers, Vasodilators, and Renin Inhibitors. To calculate the market size, the report considers the revenue generated from the sales of various hypertension drugs used in the treatment of pulmonary arterial hypertension and essential hypertension.

Global Hypertension Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Hypertension Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Buy report directly @ http://www.reportsnreports.com/Purchase.aspx?name=279935.

Key Regions
- Americas
- EMEA
- APAC

Key Vendors
- Actelion Ltd.
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Other Prominent Vendors
- Bayer AG
- Daiichi Sankyo Co. Ltd.
- Forest Laboratories Inc.
- Merck & Co. Inc.
- Takeda Pharmaceutical Co. Ltd.
- United Therapeutics Corp.
- Valeant Pharmaceuticals International Inc.
- XOMA LLC

Key Market Driver
- Increase in Aging Population.

Key Market Challenge
- Increasing Number of Patent Expirations.

Key Market Trend
- Increasing Focus on Combination Therapies.

Key Questions Answered in this Report
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?